SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-18-011074
Filing Date
2018-10-12
Accepted
2018-10-12 16:50:03
Documents
7
Period of Report
2018-10-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6k.htm 6-K 27231
2 EXHIBIT 99.1 ex991.htm EX-99.1 359338
3 EXHIBIT 99.2 ex992.htm EX-99.2 123197
4 EXHIBIT 99.3 ex993.htm EX-99.3 118700
5 EXHIBIT 99.4 ex994.htm EX-99.4 130353
6 EXHIBIT 99.5 ex995.htm EX-99.5 18830
7 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
  Complete submission text file 0001654954-18-011074.txt   788883
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 181120671
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences